Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis

Autor: E G de la Concha, Miguel Fernández-Arquero, J.A. Campillo, Amado Salvador Peña, Rafael Arroyo, J.B.A. Crusius, E. Varela de Seijas, A. Garcia-Gonalez, C. Martin
Přispěvatelé: VU University medical center
Rok vydání: 1997
Předmět:
Zdroj: de la Concha, E G, Arroyo, R, Crusius, J B A, Campillo, J A, Martin, C, Varela de Seijas, E, Peña, A S, Clavería, L E & Fernandez-Arquero, M 1997, ' Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis ', Journal of Neuroimmunology, vol. 80, pp. 172-178 . https://doi.org/10.1016/S0165-5728(97)00153-7
Journal of Neuroimmunology, 80, 172-178. Elsevier
ISSN: 0165-5728
DOI: 10.1016/s0165-5728(97)00153-7
Popis: Susceptibility to multiple sclerosis (MS) is associated with HLA-DRB1 * 1501. Many reports have suggested associations with other loci but these results remain unconfirmed. We studied the IL-1 receptor antagonist (IL-1ra) gene polymorphism and the HLA-DR and DQ allele frequencies by DNA-based methods in both the primary chronic progressive form (PP MS) and the relapsing/remitting form (R/R MS). The frequency of DRB1 * 1501 and IL-1ra allele 2 were significantly higher in R/R MS. Association was more marked in the female sex and in patients with benign forms of R/R MS. On the other hand DR4 subtypes carrying a Val at position 86 in the DR β chain were increased in PP MS. The present study indicates that MS is genetically heterogeneous and shows a combined effect of HLA-DR and IL-1ra genes in susceptibility to the R/R form of the disease.
Databáze: OpenAIRE